Update February 3rd, 2017: Jeanmarie Guenot and Amphivena have a new partnership with Takeda to advance T-Cell engagement therapies. There is hope that this will see progress in how we treat cancer long term, as well as what we understand about cancer in the body. Read about Jeanmarie’s new initiative on Takeda’s website.
Jeanmarie Guenot obtained her Ph. D. after attending the University of California at San Francisco. She then acquired her MBA from The Wharton School at the University of Pennsylvania. According to LinkedIn Guenot then founded and ran SKS Ocular a startup ophthalmic company that focused on macular degeneration, glaucoma, and ocular inflammation. She was an advisor for Hoffman-LaRoche in Shanghai, China, and Basel, Switzerland. She also served as Vice President of corporate and business development at PDL BioPharm.
Guenot began her career at Atlas Venture, where she was in charge of venture capital investments and the building of life science companies. Her scientific career began at Hoffmann-La Roche, discovering and developing medications for metabolic diseases, inflammation, autoimmune diseases, and oncology. Guenot trained in both physical and medicinal chemistry, with a focus on quantum mechanical and semi-empirical methodologies for molecular dynamics, protein structure prediction, X-ray and NMR refinement and drug design. She is currently the president of Amphivena Therapeutics, Inc. Amphivena Therapeutics is working to find treatments and therapies for hematological conditions and malignancies.
JeanMarie Guenot has had an extended career portfolio that includes project and alliance management experiences in the areas of oncology, cardiovascular diseases, neurology, autoimmune diseases, and ophthalmic diseases.
Dr. Guenot is one of the best examples of humanity who had an interest in helping others suffering the ravages of disease. Her broad experience has molded her into a dynamic woman with a disciplined mind who can apply all that she has learned to ease suffering and make the world a better place to live in for all of us.
Dr. Guenot is presently residing in San Francisco, a city she has had a strong connection to since her days at university. San Francisco is the location of her company, Ampivena Therapeutics, which is awaiting the final trial results from a very promising cancer treatment. Read more about what JeanMarie Guenot is doing on PubFacts, or follow along on her official website here: http://www.guenotllc.com/Biography.html